Overview
GIP Receptor Antagonist Studies in Humans
Status:
Completed
Completed
Trial end date:
2016-07-01
2016-07-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
Antagonizing GIP effects during hyperglycaemia in healthy subjects and measurements of insulin secretion.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University Hospital, Gentofte, CopenhagenCollaborator:
University of CopenhagenTreatments:
Gastric Inhibitory Polypeptide
Criteria
Inclusion Criteria:- Normal kidney function, liver function and hemoglobin levels.
Exclusion Criteria:
- Medication, Diabetes type 1 or 2, BMI > 25, first degree relatives with Type 2
Diabetes